Feb 21 (Reuters) - bluebird bio Inc:
* BLUEBIRD BIO ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED
BY
CARLYLE AND SK CAPITAL
* BLUEBIRD BIO INC ( BLUE ) - STOCKHOLDERS TO RECEIVE $3.00 PER SHARE
IN
CASH
* BLUEBIRD BIO INC ( BLUE ) - DAVID MEEK EXPECTED TO BECOME CEO OF
BLUEBIRD
UPON CLOSING OF DEAL
* BLUEBIRD BIO INC ( BLUE ) - STOCKHOLDERS TO RECEIVE CONTINGENT
VALUE
RIGHT OF $6.84 PER SHARE FROM DEAL
* BLUEBIRD BIO ( BLUE ): ENTERED INTO AMENDMENTS TO LOAN AGREEMENT
WITH
HERCULES CAPITAL TO FACILITATE ADEQUATE LIQUIDITY
Source text:
Further company coverage: